Every year, some mothers die after giving birth due to heart problems, and many of these deaths could be prevented. The ability to screen for heart weakness before pregnancy could play a crucial role in identifying women who may need additional care to improve pregnancy outcomes.
The ongoing shortage of donor hearts for children who need them stems from multiple causes, including a lack of donor awareness, organ allocation issues, and not enough organs that are of sufficient quality to transplant. Currently, new hearts for kids are still hard to find, and they are even scarcer for babies. Infants are particularly hard to match with a heart.
A team led by Childrenās Hospital Los Angeles has become the first in the world to demonstrate the possibility of using genetically engineered pig hearts as a potential ābridgeā to heart transplant for critically ill babies. The groundbreaking preclinical research could lead to a lifesaving alternative for supporting critically ill babies waiting for a new heartāparticularly those with single-ventricle heart disease, most of whom currently die while waiting for a transplant.
The Society of Thoracic Surgeons (STS) today announced the launch of its latest surgical risk calculator designed for patients undergoing ascending aorta and aortic root surgery, with or without concomitant aortic valve replacement (AVR).
New research has shown that hypertensive individuals who maintain optimal control of several key health risk factorsāsuch as blood pressure, cholesterol, and lifestyle behaviorsācan significantly reduce their risk of dying prematurely. The study found that with each additional risk factor brought under control, the risk of death from cancer, cardiovascular disease, and other causes dropped substantially. Most importantly, those who achieved high levels of joint risk factor control had no greater risk of early death than people without hypertension. This suggests that a comprehensive, multi-pronged approach to managing hypertension could effectively eliminate the excess mortality risk associated with the condition.
Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to encourage tissue repair and promotes survival of heart muscle cells after a heart attack.
Erythritol, a commonly used sugar substitute often marketed as āhealthy,ā may impair blood vessel health by disrupting the brainās ability to produce a critical compound, according to new research. Scientists will present their findings at the 2025 American Physiology Summit in Baltimore. The Summit is the flagship annual meeting of the American Physiological Society (APS).
Despite clear health warnings, many Americans have a hard time shaking the salt habit. New research suggests that consuming more potassium could help salt-lovers dodge some of the dangers.
A simple consultation during unrelated visits to the emergency room can help patients with high blood pressure ā āthe silent killerā ā manage the condition, even before they experience symptoms, according to new research from the University of Illinois Chicago.
Researchers with UC San Diego Health identify a potential new treatment for uncontrolled high blood pressure.
Mount Sinai-led research can transform how hospitals triage, risk-stratify, and counsel patients to save lives
Cardiology faculty practice is the only heart center in New York to receive the Pinnacle of Excellence Award
The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered by researchers at UTHealth Houston, potentially paving the way for innovative treatments that align with the natural circadian rhythm.
Field Medical Inc., a leader in cardiac pulsed field ablation (PFA) technology, announced today its FieldForceā¢ Ablation System will be featured in eight scientific presentations at the 46th annual Heart Rhythm Society (HRS) meeting, April 24ā27, in San Diego, Calif.
Statins are lifesaving to those with high cholesterol, but patients donāt always take them. A nudge that increased long-term prescriptions could be key
Of two medications given to patients, one had a much higher success rate in the study
Findings included elevated risks for chronic organ disease among children, and revealed some racial differences in long COVID risks
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right